Tokyo, Japan

Hasegawa Hideo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 3 EPO patents. Top assignees: Happy World Inc., Ilhwa Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hasegawa Hideo. Retrieved from https://idiyas.com/inventor/hasegawa-hideo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hasegawa Hideo: Innovator in Ginseng Research

Introduction

Hasegawa Hideo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of ginseng saponins. His work has implications for health and nutrition, showcasing the potential benefits of natural compounds.

Latest Patents

Hasegawa holds a patent for "Metabolites of ginseng saponins by human intestinal bacteria." This patent highlights his research into how ginseng saponins are processed by the human gut, which could lead to advancements in dietary supplements and health products. He has 1 patent to his name.

Career Highlights

Throughout his career, Hasegawa has worked with several companies, including Ilhwa Co., Ltd. and Happy World Inc. His experience in these organizations has allowed him to apply his research in practical settings, contributing to the development of innovative health products.

Collaborations

Hasegawa has collaborated with notable individuals in his field, including Jong Hwan Sung and Matsumiya Satoshi. These partnerships have enriched his research and expanded the impact of his findings.

Conclusion

Hasegawa Hideo's work in the field of ginseng research exemplifies the intersection of innovation and health. His contributions continue to influence the understanding of natural compounds and their benefits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…